A Strategic Approach to
Public & Investor Relations
At HLTH Communications, we believe that clear, strategic communication is vital for building trust and fostering strong relationships. Our expert team crafts tailored public and investor relations strategies that resonate with your audience, ensuring your brand’s message is impactful and engaging. Whether you’re in biotech, neuroscience, mental health, psychedelics, or longevity, we help you navigate complex landscapes and achieve your goals through effective and thoughtful communication.
Amplify your story, ignite your success
At HLTH Communications, we specialize in transforming your unique story into powerful narratives that resonate and inspire. Our strategic approach leverages media relations, thought leadership, and innovative content strategies to amplify your brand’s presence and impact. By aligning your message with your audience’s values and interests, we help you ignite success, drive engagement, and achieve measurable business outcomes. Let us help you turn your vision into a compelling story that captivates and delivers results.
Our Services
Designed to meet the diverse needs of our clients
Thought Leadership
Developing and promoting expert insights positions you as a leader in your field, leveraging executive commentary, bylined articles, and speaking opportunities.
Investor Relations
Build and maintain strong investor relationships through transparent communication strategies that highlight financial performance and strategic vision.
Content Strategy & Design
Compelling content creation includes brand strategy, creative writing, immersive digital experiences, and visual storytelling that resonate with your audience.
Media Relations
Achieve targeted media coverage by aligning your messaging with trends and establishing credibility through strategic campaigns.
Social Media
Engage investor communities with data-driven social media strategies that amplify your message and enhance your online presence.
Events
Ensure high engagement and seamless delivery with flawlessly planned and executed events, from large-scale conferences to intimate exhibitions.
Areas of Focus
We've helped leading brands across industries achieve measurable growth and market leadership
Biotech
We provide strategic communications for biotech companies, ensuring their groundbreaking innovations receive the attention they deserve.
Neuropsychiatry
Our expertise in neuropsychiatric communications helps companies in this field effectively convey complex medical information.
Neuroscience
Our firm supports neuroscience companies by creating compelling narratives that explain their research and breakthroughs.
Mining
We deliver strategic communications for mining companies, helping them spotlight resource potential, navigate regulatory milestones, and attract investor interest at every stage—from exploration to production.
Mental Health
We specialize in promoting mental health initiatives and organizations, using strategic communications to raise awareness and reduce stigma.
Psychedelics
We help psychedelic research and therapy companies communicate their innovative approaches and scientific findings.
Longevity
Our communications expertise in the longevity sector focuses on promoting advancements in life extension and healthy aging.
The Results
The numbers speak for themselves
$40M+
Raised for Clients
3x
Dominance in industry conversations within 6 months
65%
Average client year-over-year growth
Download Our e-Book
Discover the Secrets to Successful Communication
Client Case Studies
Learn How We Did It
Our Clients Have Been Featured In
Founders Led
Meet Our Team
Natalie Dolphin
🇨🇦 Toronto, Canada
Natalie Dolphin has over 15 years of experience in marketing, business development, and capital markets. She has a proven track record in raising capital, having secured $40M+ USD for clients, and excels in driving business growth and securing investment opportunites.
Mentions in the Press
Celebrating Our Clients' success
Executive Order For Psychedelics
A conversation with Joseph Tucker, Ph.D., CEO, Enveric Biosciences. The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.
Read Now
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies
Enveric Biosciences Inc. (NASDAQ:ENVB) on Tuesday highlighted preclinical findings for its lead candidate EB-003. It pointed to rapid reductions in PTSD-related fear responses, as recent federal policy signals growing support for psychedelic-based mental health treatments.
Read Now
Executive Order For Psychedelics
The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.
Read Now
FDA Fast-Tracks Review of Psychedelic Drugs for Mental Health Treatment
The U.S. FDA has fast-tracked the review of three psychedelic drugs being developed to treat depression, PTSD, and other mental health conditions. CGTN’s Sean Callebs spoke with Dr. Robert Discordia, Co-Founder and CEO of Equulus Therapeutics, about the science, the politics, and what accelerated approval could mean for patients.
Read Now
Latin America And The New Geopolitics Of Mining
After more than two years offline, Panama’s largest copper mine is edging back into the global supply conversation. In January, Panamanian President José Raúl Mulino said he expects to announce by June the government’s decision whether or not to reopen Cobre Panama. A full reopening would restore a major source of copper to a constrained […]
Read Now
EXCLUSIVE: Inside Kylie Jenner’s more muted look as she seemingly has fillers dissolved
The 28-year-old beauty mogul has worn some stunning dresses already this year, such as a custom ruby red Schiaparelli gown featuring a signature “keyhole” cutout and a plunging neckline to the Oscars, and a custom gold sequin Ashi Studio gown with a sweetheart neckline, which made Kylielook like a glittering trophy.
Read Now
The Business of Hlth Podcast
Listen to the latest episode of our podcast
The Business of HLTH podcast, a HLTH Communications Production, provides an in-depth look at the evolving health sector. We interview investors and innovators, exploring the latest in health tech, longevity and biotech investments, uncovering where capital is moving. Join us for insights into the future of health.
How we will work with you
Our Process
1 Research
Our initial focus will be on examining your past actions to determine what has been effective and what hasn’t. We’ll also delve into understanding your target audience, collecting essential messages and materials, and clarifying your objectives. Additionally, we’ll analyze your competitors’ marketing strategies to identify successful approaches.
2 Implementation
Following the research phase, we’ll develop and align a Media Relations program with your broader marketing strategy. This will involve setting up your press office and brainstorming pitch ideas.
3 Pitch Pitch Pitch
Through meticulous planning, organization, and interaction with journalists, we aim to secure high-quality coverage for you. This will contribute significantly to building a positive and robust media presence, which will be highly valued by your customers and search engines like Google.
4 Evaluation
You’ll have real-time access to information about our pitch efforts, ongoing conversations with targeted journalists, and all metrics related to secured coverage.
Testimonials
Hear from Happy Customers
Take Your First Steps
Are you ready to elevate your brand?
Explore how we can help you achieve your goals and drive tangible business results.